Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab Injection

NCT00864838 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT00864838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00864838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab Injection
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2009
Enrollment
56 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, diabetic retinopathy